Premium
Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany
Author(s) -
EidtKoch Daniela,
Wagner Thomas O.F.,
Mittendorf Thomas,
Reimann Andreas,
von der Schulenburg J.Matthias
Publication year - 2011
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.21364
Subject(s) - medicine , remuneration , reimbursement , activity based costing , ambulatory care , cystic fibrosis , medical prescription , emergency medicine , ambulatory , quarter (canadian coin) , intensive care medicine , pediatrics , surgery , health care , nursing , finance , business , marketing , economics , history , economic growth , archaeology
Abstract Objective Objective of this study is to assess and evaluate resource use in outpatient treatment in Germany and to compare it with remuneration. Methods Outpatient treatment was evaluated in seven different centers for pediatric and adult CF patients. Data were recorded during one representative month in 2006. A micro‐costing approach was used to value resource use data. Results For outpatient treatment mean costs (excluding drugs) of 488€ per patient per quarter occurred. Correlation analyses identified significant cost drivers including age and co‐morbidities (pancreatic insufficiency, hepatobiliary complications, lung function capacity, or bacterial lung colonization). Remuneration covered only 51% of the total costs (252€ per patient/quarter). Conclusions As the human resources available to these centers today are already below the requirements set by the European consensus for standards of CF care it will be important for a high level of patient care to reach a cost‐covering remuneration scheme. Pediatr Pulmonol. 2011; 46:278–285. © 2011 Wiley‐Liss, Inc.